Chat with us, powered by LiveChat

Loading...

Active Pharmaceutical Ingredient/ API Market Report

RA01946

Active Pharmaceutical Ingredient/ API Market, by Type (Innovative APIs, Generic APIS), Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain management, Respiratory Diseases, Other Therapeutic Applications ), Drug Type (Prescription Drugs, Over-the-counter Drugs), Type Of Manufacturer (Captive Manufacturers, Merchant Manufacturers): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA01946

Pages: 350

Feb 2023

The global active pharmaceutical ingredient/ api market is estimated to surpass $277,931.3 million by 2027, exhibiting a CAGR of 5.8% from 2020 to 2027.

The report provides all-inclusive analysis of global active pharmaceutical ingredient/ api market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.

HIGHLIGHTS OF THE REPORT

  • This report is a compilation of insights acquired via a detailed study and valid inputs from industry experts & industry participants across the value chain and quantitative & qualitative assessment by analysts of the industry
  • The report provides a comprehensive analysis along with the current trends of the market during the forecast period from 2020 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global active pharmaceutical ingredient/ api market growth
  • The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies
  • The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the active pharmaceutical ingredient/ api market
  • The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global active pharmaceutical ingredient/ api market

WHAT DOES THE REPORT OFFER?

The report emphasizes current market scenario and future trends of the global active pharmaceutical ingredient/ api market which are gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market.

In addition, the report provides market size and forecast scrutinizing the global active pharmaceutical ingredient/ api market through different segments. The report highlights the geographical market scenario of each of the segments thoroughly studied at regional as well as country level to get clearer picture of the global active pharmaceutical ingredient/ api market. In the report, the global active pharmaceutical ingredient/ api market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover the active pharmaceutical ingredient/ api market landscape in respective regions.

Furthermore, competitive scenario of the global active pharmaceutical ingredient/ api market is covered in the report. Major players functioning in the global active pharmaceutical ingredient/ api market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global active pharmaceutical ingredient/ api market, and others.

MAIN SEGMENTS OF THE MARKET

The market has been categorized based on the following segments for the convenience of research:

  • Type: Innovative APIs, Generic APIS
  • Application: Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain management, Respiratory Diseases, Other Therapeutic Applications
  • 1. RESEARCH METHODOLOGY

    • 1.1. Desk Research

    • 1.2. Real time insights and validation

    • 1.3. Forecast model

    • 1.4. Assumptions and forecast parameters

    • 1.5. Market size estimation

      • 1.5.1. Top-down approach

      • 1.5.2. Bottom-up approach

  • 2. REPORT SCOPE

    • 2.1. Market definition

    • 2.2. Key objectives of the study

    • 2.3. Report overview

    • 2.4. Market segmentation

    • 2.5. Overview of the impact of COVID-19 on Global Active Pharmaceutical Ingredient/ API Market

  • 3. EXECUTIVE SUMMARY

  • 4. MARKET OVERVIEW

    • 4.1. Introduction

    • 4.2. Growth impact forces

      • 4.2.1. Drivers

      • 4.2.2. Restraints

      • 4.2.3. Opportunities

    • 4.3. Market value chain analysis

      • 4.3.1. List of raw material suppliers

      • 4.3.2. List of manufacturers

      • 4.3.3. List of distributors

    • 4.4. Innovation & sustainability matrices

      • 4.4.1. Technology matrix

      • 4.4.2. Regulatory matrix

    • 4.5. Porter’s five forces analysis

      • 4.5.1. Bargaining power of suppliers

      • 4.5.2. Bargaining power of consumers

      • 4.5.3. Threat of substitutes

      • 4.5.4. Threat of new entrants

      • 4.5.5. Competitive rivalry intensity

    • 4.6. PESTLE analysis

      • 4.6.1. Political

      • 4.6.2. Economical

      • 4.6.3. Social

      • 4.6.4. Technological

      • 4.6.5. Environmental

    • 4.7. Impact of COVID-19 on Active Pharmaceutical Ingredient/ API Market

      • 4.7.1. Pre-covid market scenario

      • 4.7.2. Post-covid market scenario

  • 5. Active Pharmaceutical Ingredient/ API Market, By Distribution Channel

    • 5.1. Overview

    • 5.2 Innovative APIs

      • 5.2.1 Definition, key trends, growth factors, and opportunities

      • 5.2.2 Market size analysis, by region, 2020-2027

      • 5.2.3 Market share analysis, by country, 2020-2027

    • 5.3 Generic APIS

      • 5.3.1 Definition, key trends, growth factors, and opportunities

      • 5.3.2 Market size analysis, by region, 2020-2027

      • 5.3.3 Market share analysis, by country, 2020-2027

    • 5.4 Research Dive Exclusive Insights

      • 5.4.1 Market attractiveness

      • 5.4.2 Competition heatmap

  • 6. Active Pharmaceutical Ingredient/ API Market, By Device Type

    • 6.1. Overview

    • 6.2 Communicable Diseases

      • 6.2.1 Definition, key trends, growth factors, and opportunities

      • 6.2.2 Market size analysis, by region, 2020-2027

      • 6.2.3 Market share analysis, by country, 2020-2027

    • 6.3 Oncology

      • 6.3.1 Definition, key trends, growth factors, and opportunities

      • 6.3.2 Market size analysis, by region, 2020-2027

      • 6.3.3 Market share analysis, by country, 2020-2027

    • 6.4 Diabetes

      • 6.4.1 Definition, key trends, growth factors, and opportunities

      • 6.4.2 Market size analysis, by region, 2020-2027

      • 6.4.3 Market share analysis, by country, 2020-2027

    • 6.5 Cardiovascular Disease

      • 6.5.1 Definition, key trends, growth factors, and opportunities

      • 6.5.2 Market size analysis, by region, 2020-2027

      • 6.5.3 Market share analysis, by country, 2020-2027

    • 6.6 Pain management

      • 6.6.1 Definition, key trends, growth factors, and opportunities

      • 6.6.2 Market size analysis, by region, 2020-2027

      • 6.6.3 Market share analysis, by country, 2020-2027

    • 6.7 Respiratory Diseases

      • 6.7.1 Definition, key trends, growth factors, and opportunities

      • 6.7.2 Market size analysis, by region, 2020-2027

      • 6.7.3 Market share analysis, by country, 2020-2027

    • 6.8 Other Therapeutic Applications 

      • 6.8.1 Definition, key trends, growth factors, and opportunities

      • 6.8.2 Market size analysis, by region, 2020-2027

      • 6.8.3 Market share analysis, by country, 2020-2027

    • 6.9 Research Dive Exclusive Insights

      • 6.9.1 Market attractiveness

      • 6.9.2 Competition heatmap

  • 7. Active Pharmaceutical Ingredient/ API Market, By Disease Indication

    • 7.1. Overview

    • 7.2 Prescription Drugs

      • 7.2.1 Definition, key trends, growth factors, and opportunities

      • 7.2.2 Market size analysis, by region, 2020-2027

      • 7.2.3 Market share analysis, by country, 2020-2027

    • 7.3 Over-the-counter Drugs

      • 7.3.1 Definition, key trends, growth factors, and opportunities

      • 7.3.2 Market size analysis, by region, 2020-2027

      • 7.3.3 Market share analysis, by country, 2020-2027

    • 7.4 Research Dive Exclusive Insights

      • 7.4.1 Market attractiveness

      • 7.4.2 Competition heatmap

  • 8. Active Pharmaceutical Ingredient/ API Market, By Cycle Type

    • 8.1. Overview

    • 8.2 Captive Manufacturers

      • 8.2.1 Definition, key trends, growth factors, and opportunities

      • 8.2.2 Market size analysis, by region, 2020-2027

      • 8.2.3 Market share analysis, by country, 2020-2027

    • 8.3 Merchant Manufacturers

      • 8.3.1 Definition, key trends, growth factors, and opportunities

      • 8.3.2 Market size analysis, by region, 2020-2027

      • 8.3.3 Market share analysis, by country, 2020-2027

    • 8.4 Research Dive Exclusive Insights

      • 8.4.1 Market attractiveness

      • 8.4.2 Competition heatmap

  • 9. Active Pharmaceutical Ingredient/ API Market, By Region

    • 9.1 North America

      • 9.1.1 U.S

        • 9.1.1.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.1.1.2 Market size analysis, By Device Type, 2020-2027

        • 9.1.1.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.1.1.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.1.2 Canada

        • 9.1.2.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.1.2.2 Market size analysis, By Device Type, 2020-2027

        • 9.1.2.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.1.2.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.1.3 Mexico

        • 9.1.3.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.1.3.2 Market size analysis, By Device Type, 2020-2027

        • 9.1.3.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.1.3.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.1.4 Research Dive Exclusive Insights

        • 9.1.4.1 Market attractiveness

        • 9.1.4.2 Competition heatmap

    • 9.2 Europe

      • 9.2.1 Germany

        • 9.2.1.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.2.1.2 Market size analysis, By Device Type, 2020-2027

        • 9.2.1.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.2.1.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.2.2 UK

        • 9.2.2.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.2.2.2 Market size analysis, By Device Type, 2020-2027

        • 9.2.2.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.2.2.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.2.3 France

        • 9.2.3.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.2.3.2 Market size analysis, By Device Type, 2020-2027

        • 9.2.3.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.2.3.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.2.4 Spain

        • 9.2.4.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.2.4.2 Market size analysis, By Device Type, 2020-2027

        • 9.2.4.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.2.4.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.2.5 Italy

        • 9.2.5.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.2.5.2 Market size analysis, By Device Type, 2020-2027

        • 9.2.5.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.2.5.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.2.6 Rest of Europe

        • 9.2.6.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.2.6.2 Market size analysis, By Device Type, 2020-2027

        • 9.2.6.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.2.6.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.2.7 Research Dive Exclusive Insights

        • 9.2.7.1 Market attractiveness

        • 9.2.7.2 Competition heatmap

    • 9.3 Asia-Pacific

      • 9.3.1 China

        • 9.3.1.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.3.1.2 Market size analysis, By Device Type, 2020-2027

        • 9.3.1.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.3.1.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.3.2 Japan

        • 9.3.2.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.3.2.2 Market size analysis, By Device Type, 2020-2027

        • 9.3.2.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.3.2.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.3.3 India

        • 9.3.3.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.3.3.2 Market size analysis, By Device Type, 2020-2027

        • 9.3.3.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.3.3.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.3.4 Australia

        • 9.3.4.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.3.4.2 Market size analysis, By Device Type, 2020-2027

        • 9.3.4.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.3.4.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.3.5 South Korea

        • 9.3.5.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.3.5.2 Market size analysis, By Device Type, 2020-2027

        • 9.3.5.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.3.5.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.3.6 Rest of Asia-Pacific

        • 9.3.6.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.3.6.2 Market size analysis, By Device Type, 2020-2027

        • 9.3.6.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.3.6.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.3.7 Research Dive Exclusive Insights

        • 9.3.7.1 Market attractiveness

        • 9.3.7.2 Competition heatmap

    • 9.4 LAMEA

      • 9.4.1 Brazil

        • 9.4.1.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.4.1.2 Market size analysis, By Device Type, 2020-2027

        • 9.4.1.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.4.1.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.4.2 Saudi Arabia

        • 9.4.2.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.4.2.2 Market size analysis, By Device Type, 2020-2027

        • 9.4.2.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.4.2.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.4.3 UAE

        • 9.4.3.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.4.3.2 Market size analysis, By Device Type, 2020-2027

        • 9.4.3.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.4.3.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.4.4 South Africa

        • 9.4.4.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.4.4.2 Market size analysis, By Device Type, 2020-2027

        • 9.4.4.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.4.4.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.4.5 Rest of LAMEA

        • 9.4.5.1 Market size analysis, By Distribution Channel, 2020-2027

        • 9.4.5.2 Market size analysis, By Device Type, 2020-2027

        • 9.4.5.3 Market size analysis, By Disease Indication, 2020-2027

        • 9.4.5.4 Market size analysis, By Cycle Type, 2020-2027

      • 9.4.6 Research Dive Exclusive Insights

        • 9.4.6.1 Market attractiveness

        • 9.4.6.2 Competition heatmap

  • 10. Competitive Landscape

    • 10.1 Top winning strategies, 2020-2027

      • 10.1.1 By strategy

      • 10.1.2 By year

    • 10.2 Strategic overview

    • 10.3 Market share analysis, 2020-2027

  • 11. Company Profiles

    • 11.1 Pfizer, Inc.

      • 11.1.1 Overview

      • 11.1.2 Business segments

      • 11.1.3 Product portfolio

      • 11.1.4 Financial performance

      • 11.1.5 Recent developments

      • 11.1.6 SWOT analysis

    • 11.2 Novartis International AG

      • 11.2.1 Overview

      • 11.2.2 Business segments

      • 11.2.3 Product portfolio

      • 11.2.4 Financial performance

      • 11.2.5 Recent developments

      • 11.2.6 SWOT analysis

    • 11.3 Sanofi

      • 11.3.1 Overview

      • 11.3.2 Business segments

      • 11.3.3 Product portfolio

      • 11.3.4 Financial performance

      • 11.3.5 Recent developments

      • 11.3.6 SWOT analysis

    • 11.4 Boehringer Ingelheim

      • 11.4.1 Overview

      • 11.4.2 Business segments

      • 11.4.3 Product portfolio

      • 11.4.4 Financial performance

      • 11.4.5 Recent developments

      • 11.4.6 SWOT analysis

    • 11.5 Bristol-Myers Squibb

      • 11.5.1 Overview

      • 11.5.2 Business segments

      • 11.5.3 Product portfolio

      • 11.5.4 Financial performance

      • 11.5.5 Recent developments

      • 11.5.6 SWOT analysis

    • 11.6 Teva Pharmaceutical Industries Ltd.

      • 11.6.1 Overview

      • 11.6.2 Business segments

      • 11.6.3 Product portfolio

      • 11.6.4 Financial performance

      • 11.6.5 Recent developments

      • 11.6.6 SWOT analysis

    • 11.7 Eli Lilly Company

      • 11.7.1 Overview

      • 11.7.2 Business segments

      • 11.7.3 Product portfolio

      • 11.7.4 Financial performance

      • 11.7.5 Recent developments

      • 11.7.6 SWOT analysis

    • 11.8 GlaxoSmithKline plc

      • 11.8.1 Overview

      • 11.8.2 Business segments

      • 11.8.3 Product portfolio

      • 11.8.4 Financial performance

      • 11.8.5 Recent developments

      • 11.8.6 SWOT analysis

    • 11.9 Merck & Co., Inc

      • 11.9.1 Overview

      • 11.9.2 Business segments

      • 11.9.3 Product portfolio

      • 11.9.4 Financial performance

      • 11.9.5 Recent developments

      • 11.9.6 SWOT analysis

    • 11.10 AbbVie Inc

      • 11.10.1 Overview

      • 11.10.2 Business segments

      • 11.10.3 Product portfolio

      • 11.10.4 Financial performance

      • 11.10.5 Recent developments

      • 11.10.6 SWOT analysis

Purchase Options

Personalize this research

  • Triangulate with your own data
  • Request your format and definition
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed